-
1.发明申请VSTM5 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES 审中-公开VSTM5多肽及其作为治疗癌症，感染性疾病和免疫相关疾病的药物的用途公开(公告)号：US20160347814A1
公开(公告)日：2016-12-01
申请号：US15066905
申请日：2016-03-10
申请人： Compugen Ltd.
发明人： Zurit LEVINE , Galit ROTMAN , Liat DASSA , Ofer LEVY , Gad S. COJOCARU , Amir TOPORIK , Yossef KLIGER , Ilan VAKNIN , Iris HECHT
IPC分类号： C07K14/705 , A61K45/06 , G01N33/574 , A61K39/39
CPC分类号： C07K14/705 , A61K31/675 , A61K38/00 , A61K39/39 , A61K45/06 , C07K2319/00 , C07K2319/30 , C07K2319/31 , G01N33/564 , G01N33/569 , G01N33/574 , G01N33/57492 , G01N2333/4703 , G01N2333/705 , Y02A50/411 , Y02A50/423 , A61K2300/00
摘要： This invention relates to VSTM5 proteins, soluble molecules and fusions thereof which are suitable targets for drug development and for treatment of immune related disorders, immunotherapy, treatment of cancer, infectious disorders and/or sepsis.
摘要翻译： 本发明涉及VSTM5蛋白质，其可溶性分子及其融合物，其是用于药物开发和治疗免疫相关疾病，免疫治疗，癌症治疗，感染性疾病和/或败血症的合适靶标。
-
2.发明申请POLYPEPTIDES AND USES THEREOF FOR TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTION 审中-公开用于治疗自身免疫性疾病和感染的多肽及其用途公开(公告)号：US20160304579A1
公开(公告)日：2016-10-20
申请号：US15055960
申请日：2016-02-29
申请人： Compugen Ltd.
发明人： Amir TOPORIK , Avi Yeshah ROSENBERG , Galit ROTMAN , Iris HECHT , Zurit LEVINE
IPC分类号： C07K14/705 , C12N5/0783
CPC分类号： C07K14/70503 , A61K38/00 , A61K39/395 , A61K45/06 , C07K16/18 , C07K2319/30 , C07K2319/74 , C12N5/0636 , Y02A50/401
摘要： This invention relates to C1ORF32 protein and its variants and fragments and fusion proteins thereof, pharmaceutical composition comprising same and methods of use thereof for treatment of immune related disorders and infections.
摘要翻译： 本发明涉及C1ORF32蛋白及其变体及其片段和融合蛋白，包含其的药物组合物及其用于治疗免疫相关疾病和感染的方法。
-
公开(公告)号：US20180305451A1
公开(公告)日：2018-10-25
申请号：US15580723
申请日：2016-07-13
申请人： COMPUGEN LTD.
发明人： Yosef DICKEN , Liat DASSA , Amit NOVIK , Amir TOPORIK , Gad COJOCARU , Yossef KLIGER , Yair BENITA , Ofer LEVY , Ilan VAKNIN , Arthur MACHLENKIN , Iris HECHT , Jungmin KIM , Andrew POW , Andrew W DRAKE
IPC分类号： C07K16/28 , A61P35/00 , A61K39/395 , A61K45/06 , A61K31/513 , C07K14/705
CPC分类号： C07K16/2803 , A61K31/513 , A61K39/3955 , A61K45/06 , A61K2039/505 , A61K2039/572 , A61P35/00 , C07K14/70503 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/732 , C07K2317/734 , C07K2317/92 , C07K2317/94 , C07K2319/30
摘要： According to at least some embodiments of the present invention is directed to anti-HIDE1 antibodies and polypeptides and methods of using same.
-
公开(公告)号：US20220315641A9
公开(公告)日：2022-10-06
申请号：US16951130
申请日：2020-11-18
申请人： COMPUGEN, LTD.
发明人： Amir TOPORIK , Avi Yeshah ROSENBERG , Galit ROTMAN , Zurit LEVINE , Iris HECHT
IPC分类号： C07K14/705 , A61K39/395 , A61K45/06 , C07K16/18 , C12N5/0783
摘要： This invention relates to C10RF32 protein and its variants and fragments and fusion proteins thereof, pharmaceutical composition comprising same and methods of use therof for treatment of immune related disorders and infections.
-
公开(公告)号：US20210253667A1
公开(公告)日：2021-08-19
申请号：US16951130
申请日：2020-11-18
申请人： COMPUGEN, LTD.
发明人： Amir TOPORIK , Avi Yeshah ROSENBERG , Galit ROTMAN , Zurit LEVINE , Iris HECHT
IPC分类号： C07K14/705 , A61K39/395 , A61K45/06 , C07K16/18 , C12N5/0783
摘要： This invention relates to C10RF32 protein and its variants and fragments and fusion proteins thereof, pharmaceutical composition comprising same and methods of use therof for treatment of immune related disorders and infections.
-
公开(公告)号：US20190309044A1
公开(公告)日：2019-10-10
申请号：US15979097
申请日：2018-07-17
申请人： Compugen Ltd.
IPC分类号： C07K14/705 , A61P19/02 , C07K16/24 , C07K14/715 , A61K38/17 , A61K39/395 , A61P3/10 , A61P37/06 , A61P17/06
摘要： This invention, in at least some embodiments, relates to a protein C1ORF32 and its variants and fragments and fusion proteins thereof, and methods of use thereof for immunotherapy, and drug development, including but not limited to as immune modulators and for immune therapy, including for autoimmune disorders and including for inducing tolerance to a specific antigen.
-
公开(公告)号：US20190248866A1
公开(公告)日：2019-08-15
申请号：US15966694
申请日：2018-04-30
申请人： Compugen Ltd
发明人： Amir TOPORIK , Avi Yeshah ROSENBERG , Galit ROTMAN , Zurit LEVINE , Iris HECHT
IPC分类号： C07K14/705 , A61K39/395 , C12N5/0783 , A61K45/06 , C07K16/18
CPC分类号： C07K14/70503 , A61K38/00 , A61K39/395 , A61K45/06 , C07K16/18 , C07K2319/30 , C07K2319/74 , C12N5/0636 , Y02A50/401
摘要： This invention relates to C1ORF32 protein and its variants and fragments and fusion proteins thereof, pharmaceutical composition comprising same and methods of use therof for treatment of immune related disorders and infections.
-
公开(公告)号：US20190231848A1
公开(公告)日：2019-08-01
申请号：US16161017
申请日：2018-10-15
申请人： COMPUGEN LTD.
发明人： Galit ROTMAN , Iris HECHT , Zurit LEVINE , Joseph R. PODOJIL , Stephen D. Miller
IPC分类号： A61K38/17
CPC分类号： A61K38/1709 , C07K14/4713 , Y02A50/40 , Y02A50/401
摘要： This invention relates to a protein C1ORF32 and its variants and fragments and fusion proteins thereof, and methods of use thereof for immunotherapy, and drug development, including but not limited to as immune modulators and for immune therapy, including for autoimmune disorders.
-
公开(公告)号：US20170275344A1
公开(公告)日：2017-09-28
申请号：US15506770
申请日：2015-08-26
申请人： Compugen Ltd.
发明人： Iris HECHT , Joseph R. PODOJIL , Stephen D. MILLER , Eyal NERIA , Galit ROTMAN
CPC分类号： C07K14/4713 , A61K38/00 , A61K38/04 , A61K38/17 , A61K39/39541 , A61K2039/505 , C07K14/54 , C07K14/70503 , C07K16/2866 , C07K2319/00 , C07K2319/30 , G01N33/564 , G01N33/6863 , G01N2800/52 , Y02A50/401 , A61K2300/00
摘要： This invention, in at least some embodiments, relates to a protein C1ORF32 and its variants and fragments and fusion proteins thereof, and methods of use thereof for immunotherapy, and drug development, including but not limited to as immune modulators and for immune therapy, including for autoimmune disorders.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.027 秒)
